PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

National Medical Care Company

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (5)

Compared with Healthcare companies in Saudi Arabia.

P/E ratio

13.0

Investors pay 13.0 for every 1 of National Medical Care Company's yearly profit, lower than 88% of Healthcare companies in Saudi Arabia.

P/B ratio

2.09

The share price is 2.09 times National Medical Care Company's book value per share, higher than 54% of Healthcare companies in Saudi Arabia.

Market cap

SAR 3.9 B

The total market value of all of National Medical Care Company's shares at today's price (share price × number of shares), smaller than 54% of Healthcare companies in Saudi Arabia. PosiCap size class: Mini Cap.

Return on equity (ROE)

16.8%

National Medical Care Company earned 16.8% on its shareholders' money over the last year, higher than 59% of Healthcare companies in Saudi Arabia.

Dividend yield

3.44%

National Medical Care Company pays 3.44% of its share price as dividends a year, lower than 54% of dividend-paying Healthcare companies in Saudi Arabia.

Questions

What is National Medical Care Company's P/E ratio?

Investors pay 13.0 for every 1 of National Medical Care Company's yearly profit, lower than 88% of Healthcare companies in Saudi Arabia.

What is National Medical Care Company's return on equity?

National Medical Care Company earned 16.8% on its shareholders' money over the last year, higher than 59% of Healthcare companies in Saudi Arabia.

Does National Medical Care Company pay a dividend?

Yes. National Medical Care Company pays 3.44% of its share price as dividends a year, lower than 54% of dividend-paying Healthcare companies in Saudi Arabia.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.